📊 Becton, Dickinson and Company

YDX ID: bectondickin

Ticker: BDX-USA

Asset Class: Equity

Description: Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

📈 Consensus Financial Estimates (USD)

Year	Avg Revenue	Avg Net Profit	Avg EPS	Avg DPS	Avg Price Target	EPS Contributors
2026	22,822,000,000	1,786,000,000	6.24	4.48	159.05	1
2027	23,392,000,000	2,095,000,000	7.41	4.76	174.96	1
2028	24,211,000,000	2,413,000,000	8.72	5.05	192.45	1
2029	25,179,000,000	2,721,000,000	10.08	5.35	211.68	1

🔍 Analyst Views (4)

Contact erik@ywr.world to request research coverage.